Cargando…

Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy

The recent success of therapies directly targeting the angiogenic mediator, vascular endothelial growth factor (VEGF), for the treatment of proliferative diabetic retinopathy has encouraged clinicians to extend the use of anti-VEGF therapies for the treatment of another ischemic retinal vascular dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jee, Kathleen, Rodrigues, Murilo, Kashiwabuchi, Fabiana, Applewhite, Brooks P., Han, Ian, Lutty, Gerard, Goldberg, Morton F., Semenza, Gregg L., Montaner, Silvia, Sodhi, Akrit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568377/ https://www.ncbi.nlm.nih.gov/pubmed/28832635 http://dx.doi.org/10.1371/journal.pone.0183320

Ejemplares similares

Expression Pattern of HIF-1α and VEGF Supports Circumferential Application of Scatter Laser for Proliferative Sickle Retinopathy
por: Rodrigues, Murilo, et al.
Publicado: (2016)

Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
por: Babapoor-Farrokhran, Savalan, et al.
Publicado: (2015)

Hypoxia-Inducible Factor-Dependent Expression of Angiopoietin-Like 4 by Conjunctival Epithelial Cells Promotes the Angiogenic Phenotype of Pterygia
por: Meng, Qianli, et al.
Publicado: (2017)

VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy
por: Rodrigues, Murilo, et al.
Publicado: (2013)

Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma
por: Hu, Ke, et al.
Publicado: (2016)

Correction: Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma
por: Hu, Ke, et al.
Publicado: (2021)

Lack of Evidence for Vasoactive and Inflammatory Mediators in the Promotion of Macular Edema Associated with Epiretinal Membranes
por: Applewhite, Brooks P., et al.
Publicado: (2017)

Upregulation of angiopoietin-like 4 by viral G protein-coupled receptor promotes angiogenesis and vascular permeability in Kaposi’s sarcoma
por: Ma, Tao, et al.
Publicado: (2010)

Anti-angiogenic Targets: Angiopoietin and Angiopoietin Receptors
por: Kiss, Elina A., et al.
Publicado: (2019)

PAI-1 is a vascular cell–specific HIF-2–dependent angiogenic factor that promotes retinal neovascularization in diabetic patients
por: Qin, Yaowu, et al.
Publicado: (2022)

Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
por: Shaikh, Saad
Publicado: (2008)

Targeting hypoxia-inducible factors with 32-134D safely and effectively treats diabetic eye disease in mice
por: Zhang, Jing, et al.
Publicado: (2023)

Increased Angiopoietin-1 and -2 levels in human vitreous are associated with proliferative diabetic retinopathy
por: Tsai, Teresa, et al.
Publicado: (2023)

Single-cell transcriptome analyses reveal microglia types associated with proliferative retinopathy
por: Liu, Zhiping, et al.
Publicado: (2022)

Severe proliferative retinopathy in a patient with sickle cell trait
por: Caranfa, Jonathan T., et al.
Publicado: (2023)

Therapeutic Interventions against Inflammatory and Angiogenic Mediators in Proliferative Diabetic Retinopathy
por: Gologorsky, Daniel, et al.
Publicado: (2012)

Angiogenic and Vasculogenic Factors in the Vitreous from Patients with Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Amplification of the Angiogenic Signal through the Activation of the TSC/mTOR/HIF Axis by the KSHV vGPCR in Kaposi's Sarcoma
por: Jham, Bruno C., et al.
Publicado: (2011)

Angiogenic Potential of Vitreous from Proliferative Diabetic Retinopathy and Eales' Disease Patients
por: Murugeswari, Ponnalagu, et al.
Publicado: (2014)

Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2018)

Targeting proliferative retinopathy: Arginase 1 limits vitreoretinal neovascularization and promotes angiogenic repair
por: Fouda, Abdelrahman Y., et al.
Publicado: (2022)

ANGPTL4 influences the therapeutic response of patients with neovascular age-related macular degeneration by promoting choroidal neovascularization
por: Qin, Yu, et al.
Publicado: (2022)

Targeting VEGF in canine oxygen-induced retinopathy – a model for human retinopathy of prematurity
por: McLeod, D Scott, et al.
Publicado: (2016)

Correlations Between Different Angiogenic and Inflammatory Factors in Vitreous Fluid of Eyes With Proliferative Diabetic Retinopathy
por: Wu, Guanrong, et al.
Publicado: (2021)

Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management
por: Ballas, Samir K., et al.
Publicado: (2012)

Oxidative Stress, Inflammatory, Angiogenic, and Apoptotic molecules in Proliferative Diabetic Retinopathy and Diabetic Macular Edema Patients
por: Andrés-Blasco, Irene, et al.
Publicado: (2023)

Erratum to “Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management”
por: Ballas, Samir K., et al.
Publicado: (2013)

Role of Angiopoietins and Tie-2 in Diabetic Retinopathy
por: Khalaf, Nervana, et al.
Publicado: (2017)

Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report
por: Mitropoulos, Panagiotis G., et al.
Publicado: (2014)

Sickle Cell Trait Presenting as Unilateral Proliferative Retinopathy and Macular Thinning in a Pregnant Woman
por: Ghods, Sepideh, et al.
Publicado: (2021)

Regulation of Angiogenic Functions by Angiopoietins through Calcium-Dependent Signaling Pathways
por: Pafumi, Irene, et al.
Publicado: (2015)

Proliferative diabetic retinopathy transcriptomes reveal angiogenesis, anti-angiogenic therapy escape mechanisms, fibrosis and lymphatic involvement
por: Korhonen, Ani, et al.
Publicado: (2021)

Vitreous inflammatory and angiogenic factors on patients with proliferative diabetic retinopathy or diabetic macular edema: the role of Lipocalin2
por: Batsos, Georgios, et al.
Publicado: (2022)

Salmon patch-associated vitreous hemorrhage in non-proliferative sickle cell retinopathy masquerading as infectious uveitis
por: Campagnoli, Thalmon R., et al.
Publicado: (2022)

Proliferative Sickle Cell Retinopathy in the Retinal Periphery Detected by Ultra-Widefield Imaging: A Case Report
por: Giocanti-Aurégan, Audrey, et al.
Publicado: (2023)

Angiopoietins in Diabetic Retinopathy: Current Understanding and Therapeutic Potential
por: Whitehead, Michael, et al.
Publicado: (2019)

The Association of Neovascularization With Optical Coherence Tomography Angiography Parameters in Proliferative Diabetic Retinopathy
por: Sodhi, Punita K, et al.
Publicado: (2023)

Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy
por: Kwon, Jin-woo, et al.
Publicado: (2017)

High-Mobility Group Box-1 and Endothelial Cell Angiogenic Markers in the Vitreous from Patients with Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2012)

Angiopoietin-Like 7 Is an Anti-Angiogenic Protein Required to Prevent Vascularization of the Cornea
por: Toyono, Tetsuya, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1b8ell81hm162oddfv1ko333tp